General MedicationsORALStandard
TAVNEOS
AVACOPAN
Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TAVNEOS is listed in Drugs@FDA under application 214487 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient AVACOPAN Form and strength CAPSULE;ORAL - 10MG Sponsor CHEMOCENTRYX Submission history Latest submission status date: 2024-06-03 00:00:00.
Structured Monograph
Clinical summary
Approval overview TAVNEOS is listed in Drugs@FDA under application 214487 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AVACOPAN Form and strength CAPSULE;ORAL - 10MG Sponsor CHEMOCENTRYX Submission history Latest submission status date: 2024-06-03 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.